CRISPR is known for its role in gene editing, but scientists also use the technology to craft cutting-edge biological sensors that detect viral agents, gene expression changes, and environmental contaminants. CRISPR/Cas biosensors are highly sensitive, specific, and cost-effective, supporting point-of-care use without the need for technical expertise and complicated equipment. In this webinar from The Scientist, Kiana Aran and Can Dincer will discuss the benefits of CRISPR-based diagnostics and highlight advances in CRISPR-based biosensing for nucleic acid detection.
Topics to be covered
Strategies for CRISPR biosensor development
Detection of unamplified targets with CRISPR biosensors
Friday, March 12, 2021
2:30 - 4:00 PM, Eastern Time
Speakers
Kiana Aran, PhD Co-founder and Chief Scientific Officer Cardea Bio Assistant Professor, Medical Diagnostics and Therapeutics Keck Graduate Institute Visiting Assistant Professor University of California, Berkeley
Can Dincer, PhD Junior Research Group Leader, Freiburg Center for Interactive Materials and Bioinspired Technologies Department of Microsystems Engineering University of Freiburg, Germany
Register Now
CRISPR Biosensors for Disease Diagnostics
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
